Osteoporosis
Research on Osteoporosis Discussed by M. Tanaka and Co-Researchers
Published in Women's Health Weekly, June 16th, 2011
2011 JUN 16 -- A new study, "Effects of raloxifene on bone mineral metabolism in postmenopausal Japanese women on hemodialysis," is now available. "In addition to renal osteodystrophy, postmenopausal women on hemodialysis are at high risk for osteoporosis. Recent studies reported the effects of raloxifene, a selective estrogen receptor modulator for osteoporosis, in postmenopausal women," scientists writing in the journal Therapeutic Apheresis and Dialysis report.
"The present study evaluated the efficacy of raloxifene and its effects on bone mineral metabolism in postmenopausal Japanese patients on dialysis. In a prospective, multicentre study, 17...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
BioSante Pharmaceuticals Completes Enrollment in LibiGel(R) Phase III Safety Study - Breast Cancer
Data on Breast Cancer Described by Researchers at National Cancer Institute - Breast Cancer
Data on Breast Cancer Discussed by Researchers at INSERM - Breast Cancer
Data on Breast Cancer Discussed by Researchers at University of Sao Paulo - Cesarean Section
Data on Cesarean Section Discussed by Researchers at University of Colorado - Cesarean Section
Data on Cesarean Section Published by Researchers at Wayne State University - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
